LNSR
LENSAR Inc.
Company Overview
| Mkt Cap | $128.40M | Price | $5.53 |
| Volume | 49.47K | Change | -1.78% |
| P/E Ratio | -4.1 | Open | $5.73 |
| Revenue | $53.5M | Prev Close | $5.63 |
| Net Income | $-31.4M | 52W Range | $5.35 - $14.31 |
| Div Yield | N/A | Target | $8.50 |
| Overall | 42 | Value | 40 |
| Quality | 50 | Technical | 36 |
No chart data available
About LENSAR Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Latest News
Wall Street Analysts Are Bullish on Top Healthcare Picks
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR)
LENSAR Ends Alcon Merger, Plans Strategic Update
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LNSR | $5.53 | -1.8% | 49.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |